Clinical Trial Update: Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating trastuzumab, cyclophosphamide, and a vaccine therapy in high-risk or metastatic breast cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Trastuzumab (trastuzumab)
• Vaccine therapy

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-09-26